The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy.
The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy.
复制标题
DOI:
10.1007/s10549-012-2116-3
复制
发表时间:
2012-07
影响因子:
3.8
通讯作者:
Griggs JJ
中科院分区:
文献类型:
--
作者:
Pini TM;Hawley ST;Li Y;Katz SJ;Griggs JJ
The extent to which medical oncologists consider non-clinical patient factors when deciding to recommend adjuvant chemotherapy is unknown. Medical oncologists who treated a population-based sample of early-stage breast cancer patients reported to the Los Angeles and Detroit Surveillance, Epidemiology, and End Results registries 2005–2007 were asked how strongly they consider a patient’s ability to follow instructions, level of social support, and level of work support/flexibility in decisions to recommend adjuvant chemotherapy. Responses of 4 (Quite strongly) or 5 (Very strongly) on a 5-point Likert scale defined strong consideration. Associations between oncologist/practice characteristics and strong consideration of each non-clinical factor were examined. 134 oncologists (66%) reported strong consideration of one or more factor. Ability to follow instructions was strongly considered by 120 oncologists (59%), social support by 78 (38%), and work support/flexibility by 73 (36%). Larger percent of practice devoted to breast cancer was associated with lower likelihood of strongly considering ability to follow instructions [odds ratio (OR) 0.98, 95% confidence interval (CI) 0.97–0.99; P=0.04]. Increased years in practice was associated with lower likelihood of strongly considering social support (OR 0.96, CI 0.93–0.99; P=0.011), while non-white race (OR 2.1, CI 1.03–4.26; P=0.041) and tumor board access (OR 2.04, CI 1.01–4.12; P=0.048) were associated with higher likelihood. Non-white race was associated with strongly considering work support/flexibility (OR 2.44, CI 1.21–4.92; P=0.013). Tumor board access (OR 2, CI 1.00–4.02; P=0.051) was borderline significant. Non-clinical patient factors play a role in medical oncologist decision-making for breast cancer adjuvant chemotherapy recommendations.
登录
查看更多内容
影响因子:
3
作者:
Katz SJ;Hawley ST;Morrow M;Griggs JJ;Jagsi R;Hamilton AS;Graff JJ;Friese CR;Hofer TP
通讯作者:
Hofer TP
影响因子:
5.9
作者:
Southern, William N.;Bellin, Eran Y.;Arnsten, Julia H.
通讯作者:
Arnsten, Julia H.
影响因子:
45.3
作者:
Keating, Nancy L.;Landrum, Mary Beth;Kahn, Katherine L.
通讯作者:
Kahn, Katherine L.
影响因子:
10.3
作者:
Hawley, Sarah T.;Griggs, Jennifer J.;Katz, Steven J.
通讯作者:
Katz, Steven J.
影响因子:
12.7
作者:
van Ryn, M;Burgess, D;Griffin, J
通讯作者:
Griffin, J